SMAD4 clue to colon cancer

Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States.

Reporting last month in the journal Cellular and Molecular Gastroenterology and Hepatology, Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.

SMAD4 is part of the transforming growth factor beta (TGF-beta) signaling pathway that in the epithelium of the colon regulates the immune/inflammatory response to infection.

Specific deletion of the Smad4gene in normal mouse colon epithelial cells grown in vivo increased the expression of inflammatory mediators. In adult mice in the presence of inflammation, deletion resulted in tumors bearing a striking resemblance to human colitis-associated carcinoma.

Source: Read Full Article